CIBC Bancorp USA Inc. Acquires New Holdings in CME Group Inc. $CME

CIBC Bancorp USA Inc. bought a new position in shares of CME Group Inc. (NASDAQ:CME) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 55,330 shares of the financial services provider’s stock, valued at approximately $14,950,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Caldwell Trust Co increased its holdings in shares of CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 50 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new stake in CME Group during the third quarter valued at about $27,000. Financial Consulate Inc. bought a new stake in CME Group during the third quarter valued at about $28,000. Sagard Holdings Management Inc. purchased a new position in CME Group in the second quarter valued at about $30,000. Finally, Corundum Trust Company INC purchased a new position in CME Group in the third quarter valued at about $30,000. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the subject of several analyst reports. Barclays increased their price target on shares of CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. Bank of America boosted their price objective on shares of CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. JPMorgan Chase & Co. increased their target price on shares of CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a research report on Thursday, February 5th. TD Cowen raised their target price on shares of CME Group from $305.00 to $328.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Finally, Jefferies Financial Group upped their price target on CME Group from $302.00 to $356.00 and gave the stock a “buy” rating in a research report on Monday, March 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $304.06.

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the firm’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares of the company’s stock, valued at $2,397,597.04. This trade represents a 31.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Bryan T. Durkin sold 4,200 shares of the business’s stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the transaction, the director owned 43,007 shares of the company’s stock, valued at $13,317,117.55. This represents a 8.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 8,539 shares of company stock worth $2,713,821 in the last ninety days. 0.30% of the stock is owned by company insiders.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Goldman Sachs published a bullish forecast for CME, calling for strong price appreciation — this likely supported upside sentiment among investors. Goldman Sachs Forecasts Strong Price Appreciation for CME Group
• Neutral Sentiment: Analyst coverage remains mixed but constructive overall: multiple firms maintain buy/overweight stances and some price targets (e.g., TD Cowen, Morgan Stanley) are above the current trading level, while others (e.g., JP Morgan) are more conservative — this creates a balanced catalyst set for price discovery. Quiver Quant – Analyst ratings & price targets summary
• Neutral Sentiment: Reported short-interest data for March shows zero shares shorted (days-to-cover 0.0), but the figures look erroneous/artefactual (NaN and repeated 0 values). As reported, this offers no reliable signal on bearish positioning.
• Negative Sentiment: Insider selling: CME’s Senior MD & General Counsel Jonathan L. Marcus sold 3,291 shares (~$1.1M) on March 17, reducing his stake by ~31%. Market participants often view sizable insider sales as a short-term negative signal. SEC Form 4 – Marcus sale
• Negative Sentiment: Aggregated insider activity over recent months shows more sales than buys (multiple senior executives have sold shares), which can weigh on sentiment if investors interpret this as executives taking gains rather than signaling long-term conviction. Quiver Quant – Insider activity

CME Group Stock Performance

Shares of CME stock opened at $310.71 on Friday. The business has a fifty day moving average of $299.19 and a 200 day moving average of $280.13. CME Group Inc. has a 1 year low of $248.53 and a 1 year high of $329.16. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.03. The firm has a market capitalization of $112.04 billion, a price-to-earnings ratio of 27.84, a price-to-earnings-growth ratio of 3.34 and a beta of 0.24.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the business earned $2.52 EPS. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. As a group, research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be issued a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date is Tuesday, March 10th. This represents a $5.20 annualized dividend and a yield of 1.7%. CME Group’s dividend payout ratio is currently 46.59%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.